Skip to content
Shameless Cloning

Search Shameless Cloning

Search superinvestors, stocks, insiders and members of Congress

Q2 2026 13F · SEC CIK 1851813

Hackensack Meridian Health, Inc.

Investment managerFiled 2026-08-05 for Q2 2026. Open the filing ↗ · All SEC filings ↗

Reported 13F value
$1.5B
Reported positions
7
Top holdings a year, 3 yrs
+20.0%
Average holding period
3.1 yrs

Hackensack Meridian Health, Inc. is an investment manager that reported 7 positions worth $1.5B in its Q2 2026 13F, filed 2026-08-05. Its largest holdings were State Str Spdr S&p 500 ETF T (SPY, 35.7%), Ishares Tr (EFA, 19.8%), Ishares Inc (IEMG, 12.6%). A portfolio copying its top holdings returned 20.0% a year over the last 3 years, against 22.3% for the S&P 500.

Hackensack Meridian Health, Inc. holdings all 7 positions.

Weights are shares of the filer's total reported 13F value, compared with Q1 2026. Share changes may reflect splits; weight changes also reflect price moves. A 13F shows long US-listed positions only, up to 135 days after the fact.

Hackensack Meridian Health, Inc. 13F holdings
Stock% of 13F valueShare changeReported value
SPYState Str Spdr S&p 500 ETF T35.7%+33.1%$528.3M
EFAIshares Tr19.8%+18.5%$293.4M
IEMGIshares Inc12.6%+6.2%$186.1M
IWFIshares Tr11.0%+300.0%$163.1M
EFVIshares Tr10.9%+146.3%$160.8M
GNRSpdr Index Shs Fds8.5%+16.7%$126.2M
ACWIIshares Tr1.6%+74.1%$23.2M

What Hackensack Meridian Health, Inc. bought and sold in Q2 2026, against Q1 2026.

New positions

No new positions among the largest holdings.

Added to

Reduced

No position shrank by more than 5%.

Sold out

Nothing sold out.

Share counts compared with the Q1 2026 13F; a split also changes share counts.

How the holdings did against the S&P 500.

1 year
+12.7% /yr
S&P 500 +11.7%
3 years
+20.0% /yr
S&P 500 +22.3%
5 years
+9.5% /yr
S&P 500 +12.3%

A portfolio of the filer's 20 largest 13F positions, weighted by value, bought the trading day after each 13F was filed and held until the next one was: what copying this filer could have earned. 13Fs show long US-listed positions only, so this is an estimate of the stock picks, not the fund's reported returns.

Reported 13F value by quarter.

13F value by quarter
Quarter13F valuePositions
Q2 2026$1.5B7
Q1 2026$1.1B7
Q4 2025$1.1B7
Q3 2025$973.4M6
Q2 2025$902.8M6
Q1 2025$878.9M6
Q4 2024$841.9M6
Q3 2024$973.9M6
Q2 2024$750.2M6
Q1 2024$743.9M6
Q3 2023$673.7M6
Q2 2023$728.6M6

Questions about Hackensack Meridian Health, Inc.'s portfolio

What stocks does Hackensack Meridian Health, Inc. own?

Hackensack Meridian Health, Inc.'s latest 13F, for Q2 2026 and filed Aug 5, 2026, lists 7 positions worth $1.5B. The largest are State Str Spdr S&p 500 ETF T (SPY) at 35.7%, Ishares Tr (EFA) at 19.8%, Ishares Inc (IEMG) at 12.6%, Ishares Tr (IWF) at 11.0% and Ishares Tr (EFV) at 10.9%.

What did Hackensack Meridian Health, Inc. buy last quarter?

In Q2 2026, Hackensack Meridian Health, Inc. added Ishares Tr (IWF) (+300.0% shares), Ishares Tr (EFV) (+146.3% shares) and Ishares Tr (ACWI) (+74.1% shares), compared with its Q1 2026 filing.

What did Hackensack Meridian Health, Inc. sell last quarter?

Hackensack Meridian Health, Inc. sold out of nothing and cut no large position by more than 5% in Q2 2026.

How has Hackensack Meridian Health, Inc.'s portfolio performed?

A portfolio copying Hackensack Meridian Health, Inc.'s 20 largest 13F holdings each quarter, from the day each filing was public, returned +20.0% a year over the last 3 years, against +22.3% for the S&P 500. Over 1 year: +12.7% against +11.7%. Over 5 years: +9.5% a year against +12.3%.

When is Hackensack Meridian Health, Inc.'s next 13F filing due?

13F filings are due 45 days after each quarter ends. Hackensack Meridian Health, Inc.'s filing for the quarter ending Sep 30, 2026 is due by Nov 14, 2026; this page updates the day after it is published.